Drug Reformulations and Repositioning in Pharmaceutical Industry and Its Impact on Market Access: Reassessment of Nomenclature
Abstract
Share and Cite
Murteira, S.; Ghezaiel, Z.; Karray, S.; Lamure, M. Drug Reformulations and Repositioning in Pharmaceutical Industry and Its Impact on Market Access: Reassessment of Nomenclature. J. Mark. Access Health Policy 2013, 1, 21131. https://doi.org/10.3402/jmahp.v1i0.21131
Murteira S, Ghezaiel Z, Karray S, Lamure M. Drug Reformulations and Repositioning in Pharmaceutical Industry and Its Impact on Market Access: Reassessment of Nomenclature. Journal of Market Access & Health Policy. 2013; 1(1):21131. https://doi.org/10.3402/jmahp.v1i0.21131
Chicago/Turabian StyleMurteira, Susana, Zied Ghezaiel, Slim Karray, and Michel Lamure. 2013. "Drug Reformulations and Repositioning in Pharmaceutical Industry and Its Impact on Market Access: Reassessment of Nomenclature" Journal of Market Access & Health Policy 1, no. 1: 21131. https://doi.org/10.3402/jmahp.v1i0.21131